Vasomune Therapeutics is at the 38th J.P. Morgan Healthcare Conference

Ronald Zahoruk
January 15, 2020
Uncategorized

Vasomune Therapeutics is currently attending the 38TH ANNUAL JPM HEALTHCARE CONFERENCE, San Francisco, California

About

Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

Close Menu

You Might Also Like

Vasomune Therapeutics and AnGes, Inc. enter into a Multi-Million Dollar Global Co-Development Agreement to Advance an Innovative Platform Targeting Vascular Leakage

Vasomune Therapeutics Appoints Meenu Chhabra to its Board of Directors

Vasomune’s Lead Investigational Medication is Connected to the Fight Against Coronavirus

About

Vasomune Therapeutics 2019 © All Rights Reserved.